In the News

05/22/2019

TMAO and Heart Disease: The New Red Meat Risk?

Over the past several decades, public health experts and physicians have pinned a hefty portion of the blame for heart disease on saturated fat. That’s not without reason. The long-chain saturated fatty acids found in foods like steak, butter, and coconut oil raise artery-clogging low–density lipoprotein (LDL) cholesterol, a cause of atherosclerotic cardiovascular disease. At the same time, diets high in red meat have been strongly associated with heart disease and mortality.


05/13/2019

Hospitals look to computers to predict patient emergencies before they happen

Seven floors, and long odds, were stacked against John S. He was undergoing a test on the first floor of a Cleveland Clinic hospital when his nursing team — on the eighth floor — got a call, telling them the 57-year-old had developed a dangerously rapid heartbeat that was spiraling toward cardiac arrest.


05/01/2019

'They've given me hope': NE Ohio design teams create solutions for disabled veterans

Tables at the Joseph and Helen Lowe Institute for Innovation were strewn with laptop computers, cell phones, electronics and cables.

The surrounding walls were covered with scientific graffiti in drawings, notes and questions to be answered.

It was the stuff of creativity and inspiration, all of it needed to help make the lives of seven disabled veterans a bit easier.


04/28/2019

Why Cleveland Clinic is partnering with a manufacturer known for ecommerce

Proto Labs and Cleveland Clinic are jointly developing an awards program to help move novel healthcare ideas forward, says Proto Labs CEO Vicki Holt. The new initiative will be part of Proto Labs’ Cool Idea Award program and will work with Cleveland Clinic Innovations, which says it has executed over 500 licenses and created 75 spin-off companies that have raised over $1 billion in equity investment and commercialization grants since 2000.


04/26/2019

Cleveland Clinic, Kent State University and two Cleveland-area companies land Third Frontier grants

Cleveland Clinic and Kent State University both received grants from the Third Frontier's Technology Validation and Start-up Fund, which provides grants to higher education and other nonprofit research institutions "to demonstrate that a technology is commercially viable through activities such as testing and prototyping," with the ultimate goal of licensing the technology to companies.


04/23/2019

Protolabs partners with Cleveland Clinic Healthcare Innovations Alliance

Protolabs has forged a partnership with the Cleveland Clinic Healthcare Innovations Alliance to create an awards program that will accelerate healthcare ideas.


04/23/2019

Protolabs teams up with Cleveland Clinic to bring ‘cool ideas’ to medtech market

Digital manufacturing company Protolabs (Maple Plain, MN) has teamed up with the Cleveland Clinic Healthcare Innovation Alliance to help bring novel healthcare ideas to fruition. Part of Protolabs' Cool Idea Award program, the winning submissions will receive in-kind manufacturing services from Protolabs to support development and eventual commercialization of the products.


04/23/2019

Cleveland Clinic spinoff company to start clinical trials for Alzheimer's disease

Cleveland Clinic spinoff company NeuroTherapia Inc. will start clinical trials of a new drug targeting inflammation of the brain that's found in Alzheimer's and other neurological diseases, according to a news release.


04/23/2019

Cleveland Clinic Innovations teams up with digital manufacturing company to offer innovation award

Minnesota-based digital manufacturing company Protolabs (NYSE: PRLB) has teamed up with the Cleveland Clinic Healthcare Innovations Alliance — a network of health care organizations, corporations and universities focused on innovation in health care — to offer an awards program to help propel novel health care ideas.


04/22/2019

Neurotherapia to Start Clinical Trials of NTRX-07 For Alzheimer’s Disease

NeuroTherapia, Inc., a Cleveland Clinic spin-off company, will be starting clinical trials of NTRX-07, a new drug targeting inflammation in the brain that is found in Alzheimer’s disease (AD) and other neurological diseases.


   < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >   

Get In Touch With Us